CHELSEA SHELTON: Open Payments
NPI 1144639246 · ONEIDA, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$446 in 22 payments from 12 companies in 2025. Trend: 2023 $1,093 · 2024 $730 · 2025 $446
Food & beverage: $446
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 5 | $107 |
| ABBVIE INC. | 3 | $77 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $52 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $48 |
| Novo Nordisk Inc | 2 | $40 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $24 |
| Axsome Therapeutics, Inc. | 1 | $18 |
| Lilly USA, LLC | 1 | $17 |
| AstraZeneca Pharmaceuticals LP | 1 | $17 |
| Xeris Pharmaceuticals, Inc. | 1 | $16 |
Products named: TRELEGY ELLIPTA, VRAYLAR, CAPLYTA, Kerendia, Ozempic, XIFAXAN, AREXVY, Auvelity.
Industry payments across TN — which companies pay providers there.
